4.6 Article

Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans

期刊

PLOS ONE
卷 8, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0048979

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases [R01-AI068804, K24-AI093969, 5U01AI066569-05, 3U01AI066569-05S1]
  2. Wallace H. Coulter Foundation
  3. Novartis Vaccines and Diagnostics, Inc.
  4. Cubist Pharmaceuticals
  5. Novartis Pharmaceuticals
  6. Roche Molecular Diagnostics
  7. Veterans Affairs Career Development Award
  8. Astellas Pharma US
  9. Merck
  10. Theravance
  11. Cerexa
  12. Pfizer
  13. Novartis
  14. MedImmune
  15. Advance Liquid Logic
  16. National Institutes of Health
  17. Agennix AG
  18. Alere Corporation

向作者/读者索取更多资源

Staphylococcus aureus causes a spectrum of human infection. Diagnostic delays and uncertainty lead to treatment delays and inappropriate antibiotic use. A growing literature suggests the host's inflammatory response to the pathogen represents a potential tool to improve upon current diagnostics. The hypothesis of this study is that the host responds differently to S. aureus than to E. coli infection in a quantifiable way, providing a new diagnostic avenue. This study uses Bayesian sparse factor modeling and penalized binary regression to define peripheral blood gene-expression classifiers of murine and human S. aureus infection. The murine-derived classifier distinguished S. aureus infection from healthy controls and Escherichia coli-infected mice across a range of conditions (mouse and bacterial strain, time post infection) and was validated in outbred mice (AUC>0.97). A S. aureus classifier derived from a cohort of 94 human subjects distinguished S. aureus blood stream infection (BSI) from healthy subjects (AUC 0.99) and E. coli BSI (AUC 0.84). Murine and human responses to S. aureus infection share common biological pathways, allowing the murine model to classify S. aureus BSI in humans (AUC 0.84). Both murine and human S. aureus classifiers were validated in an independent human cohort (AUC 0.95 and 0.92, respectively). The approach described here lends insight into the conserved and disparate pathways utilized by mice and humans in response to these infections. Furthermore, this study advances our understanding of S. aureus infection; the host response to it; and identifies new diagnostic and therapeutic avenues.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据